000 01125 a2200325 4500
005 20250518101314.0
264 0 _c20210906
008 202109s 0 0 eng d
022 _a1476-5462
024 7 _a10.1038/s41434-020-0153-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAli, Gibran
245 0 0 _aAdvances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment.
_h[electronic resource]
260 _bGene therapy
_c02 2021
300 _a6-15 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aCRISPR-Cas Systems
650 0 4 _aGene Editing
650 0 4 _aHumans
650 0 4 _aRetrospective Studies
650 0 4 _aTechnology
650 0 4 _abeta-Globins
_xgenetics
650 0 4 _abeta-Thalassemia
_xgenetics
700 1 _aTariq, Muhammad Akram
700 1 _aShahid, Kamran
700 1 _aAhmad, Fridoon Jawad
700 1 _aAkram, Javed
773 0 _tGene therapy
_gvol. 28
_gno. 1-2
_gp. 6-15
856 4 0 _uhttps://doi.org/10.1038/s41434-020-0153-9
_zAvailable from publisher's website
999 _c30920897
_d30920897